Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus Hypersecretion
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- University of North Carolina, Chapel Hill
- Study ID
- NCT07873632
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Bronchitis
- Bronchitis, Chronic
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Glycerol Guiacolate — DRUGParticipants will receive 28 days (+3 days for flexible scheduling) dosing of Glycerol Guiacolate (GGE) (2 x 600 mg for a total of 1200mg) taken twice daily (total of 2400 mg) in addition to current medications.
- SOC (Standard of care) — DRUGCurrent medication excluding mucolytics or steroids
Study Details
A Randomized, Dosing vs Standard of Care, Single-Center, Multiple Dose Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus Hypersecretion
Key Dates
- First listed
- Oct 14, 2026
- Start date
- Oct 31, 2026
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2027
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Glycerol GuiacolateGlycerol Guiacolate (Mucinex) Extended release 2 x 600 mg tablets bis in die (BID)
- Other: Standard of CareCurrent medication Participant is currently using
Primary Outcome Measure
Change in mucus viscosity [ Time Frame: Baseline to end of treatment (Day 28) ]
Central Contacts
- Brian Button, PhD919-966-8073
- Carole Robinette, MS, CPFT, ACSM:CEP919-966-5638
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Marsico Lung Institute | Chapel Hill | North Carolina | 27599 | Carole Robinette, MS, CPFT, ACSM:CEP |
Find similar trials in Chapel Hill, NC
By research site
Related Studies
- Analysis of the Virtual Acute Care at Home ExperienceEnrolling By Invitation · OSF Healthcare System · Peoria, Illinois
- How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.Recruiting · Geisinger Clinic · Bloomsburg, Pennsylvania